A case presentation involving a patient with severe, symptomatic iliofemoral deep vein thrombosis and need for urgent ...

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion.

The FDA has granted Priority Review status to Regeneron’s and Bayer’s supplemental Biologics License Application (sBLA) for Eylea HD (aflibercept) injection 8 mg. The application seeks to expand use ...

Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion. Gill, vice chair of clinical performance and ophthalmology professor at ...

for aflibercept injection 8mg for the treatment of macular edema following retinal vein occlusion (RVO) and monthly dosing across all approved indications. The sBLA was supported by data from the ...

EYLEA HD is a treatment for retinal vein occlusion (RVO) that allows for dosing every 8 weeks after initial monthly doses, potentially halving injections. What is the FDA's action date for EYLEA ...

Considering taking supplements to treat retinal vein occlusion? Below is a list of common natural remedies used to treat or reduce the symptoms of retinal vein occlusion. Follow the links to read ...

The All-Star guard had been sidelined since March 18 with deep vein thrombosis in his right calf. Michael Marot | The Associated Press Damian Lillard’s return to action wasn’t enough to help ...

At the J.P. Morgan Healthcare Conference in January, Regeneron CEO Leonard Schleifer said that the company’s new formulation of eye disease treatment Eylea needed “a few more arrows in its ...

An axial image of the abdomen and pelvis (Panel C) shows a nearly occlusive thrombus in the left renal vein and a nonocclusive thrombus in the right renal vein (arrows). Dr. Manning: The patient ...

In just the last two months, both Damian Lillard of the Milwaukee Bucks and the San Antonio Spurs' Victor Wembanyama were diagnosed with deep vein thrombosis. Wembanyama's clot was discovered in ...